Discover
AIDX
20/20 Biolabs, Inc.
0.62
1 x 0.61
1 x 1.00
bid
ask
-
0.01
1.25%
1 @ 06:02 PM
0.65 +0.03 (5.00%)
| Ytd | -97.42% | |
| 1y | -97.42% |
0.62
day range
0.65
0.40
52 week range
23.85
| Open | 0.65 | Prev Close | 0.62 | Low | 0.62 | High | 0.65 | Mkt Cap | 7.87M |
| Vol | 36.86K | Avg Vol | 632.10K | EPS | -0.57 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.53 | 200-d Avg | 1.66 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 730.57K | ||
| Revenues (USD) | 730.57K | ||
| Cost of Revenue | 425.84K | ||
| Gross Profit | 304.73K | ||
| Operating Expenses | 1.55M | ||
| Research and Development Expense | 257.63K | ||
| Selling, General and Administrative Expense | 1.29M | ||
| Operating Income | -1.24M | ||
| Interest Expense | 272.25K | ||
| Net Income | -1.51M | ||
| Net Income Common Stock | -2.75M | ||
| Net Income Common Stock (USD) | -2.75M | ||
| Consolidated Income | -1.51M | ||
| Earnings per Basic Share | -0.26 | ||
| Earnings per Basic Share (USD) | -0.26 | ||
| Earnings per Diluted Share | -0.26 | ||
| Earning Before Interest & Taxes (EBIT) | -1.23M | ||
| Earning Before Interest & Taxes (USD) | -1.23M | ||
| Preferred Dividends Income Statement Impact | 1.25M | ||
| Weighted Average Shares | 10.79M | ||
| Weighted Average Shares Diluted | 10.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.55M | ||
| Cash and Equivalents (USD) | 4.55M | ||
| Trade and Non-Trade Receivables | 291.49K | ||
| Current Assets | 5.08M | ||
| Property, Plant & Equipment Net | 553.00K | ||
| Total Assets | 6.12M | ||
| Debt Current | 192.73K | ||
| Total Debt | 572.45K | ||
| Current Liabilities | 2.55M | ||
| Debt Non-Current | 379.72K | ||
| Total Liabilities | 2.96M | ||
| Accumulated Retained Earnings (Deficit) | -36.93M | ||
| Shareholders Equity | 1.62M | ||
| Shareholders Equity (USD) | 1.62M | ||
| Assets Non-Current | 1.05M | ||
| Total Debt (USD) | 572.45K | ||
| Deferred Revenue | 499.96K | ||
| Goodwill and Intangible Assets | 471.50K | ||
| Inventory | 111.04K | ||
| Liabilities Non-Current | 412.64K | ||
| Trade and Non-Trade Payables | 1.03M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 16.69K | ||
| Net Cash Flow from Financing | 940.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 327.04K | ||
| Net Cash Flow from Investing | -7.50K | ||
| Net Cash Flow from Operations | -605.46K | ||
| Share Based Compensation | 552.80K | ||